ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Terbinafine (Lamisil) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-31S7666
Home | Market Reports | Health| Pharmacy
Global Terbinafine Lamisil Market Insights and Forecast to 2028
BUY CHAPTERS

Global Terbinafine (Lamisil) Market Research Report 2025

Code: QYRE-Auto-31S7666
Report
July 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Perrigo
Novartis Pharmaceuticals Corporation
Gokul Pharma
TEVA
Mylan Pharmaceuticals
Pfizer Inc
Sivem Pharmaceuticals
Apotex Corporation
Auro Pharma Inc
PLIVA
Jamp Pharma Corporation
Nu Pharm
Codal Synto
Qd Pharmaceuticals
Pharmel Inc
Smaart Pharmaceutticals
Qilu Pharmaceutical
Qingdao Jinfeng Pharmaceutical

Terbinafine (Lamisil) Market

The global market for Terbinafine (Lamisil) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Terbinafine is also known as Terbinafine hydrochloride (Lamisil).It is a synthetic allylamine antifungal.It is highly lipophilic in nature and tends to accumulate in skin, nails, and fatty tissues.Like other allylamines, terbinafine inhibits ergosterol synthesis by inhibiting the fungal squalene monooxygenase (also called squalene epoxidase), an enzyme that is part of the fungal cell wall synthesis pathway.
North American market for Terbinafine (Lamisil) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Terbinafine (Lamisil) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Terbinafine (Lamisil) include Perrigo, Novartis Pharmaceuticals Corporation, Gokul Pharma, TEVA, Mylan Pharmaceuticals, Pfizer, Sivem Pharmaceuticals, Apotex Corporation, Auro Pharma Inc, PLIVA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Terbinafine (Lamisil), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terbinafine (Lamisil).
The Terbinafine (Lamisil) market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Terbinafine (Lamisil) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terbinafine (Lamisil) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Terbinafine (Lamisil) Market Report

Report Metric Details
Report Name Terbinafine (Lamisil) Market
Segment by Type
  • Oral
  • External Use
Segment by Application
  • Fungal Infection Of The Skin And Mucous Membrane
  • Onychomycosis
  • Bronchial Asthma
  • Gynecological Anti-Infection Preparation
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Perrigo, Novartis Pharmaceuticals Corporation, Gokul Pharma, TEVA, Mylan Pharmaceuticals, Pfizer, Sivem Pharmaceuticals, Apotex Corporation, Auro Pharma Inc, PLIVA, Jamp Pharma Corporation, Nu Pharm, Codal Synto, Qd Pharmaceuticals, Pharmel Inc, Smaart Pharmaceutticals, Qilu Pharmaceutical, Qingdao Jinfeng Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Terbinafine (Lamisil) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Terbinafine (Lamisil) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Terbinafine (Lamisil) Market report?

Ans: The main players in the Terbinafine (Lamisil) Market are Perrigo, Novartis Pharmaceuticals Corporation, Gokul Pharma, TEVA, Mylan Pharmaceuticals, Pfizer, Sivem Pharmaceuticals, Apotex Corporation, Auro Pharma Inc, PLIVA, Jamp Pharma Corporation, Nu Pharm, Codal Synto, Qd Pharmaceuticals, Pharmel Inc, Smaart Pharmaceutticals, Qilu Pharmaceutical, Qingdao Jinfeng Pharmaceutical

What are the Application segmentation covered in the Terbinafine (Lamisil) Market report?

Ans: The Applications covered in the Terbinafine (Lamisil) Market report are Fungal Infection Of The Skin And Mucous Membrane, Onychomycosis, Bronchial Asthma, Gynecological Anti-Infection Preparation, Other

What are the Type segmentation covered in the Terbinafine (Lamisil) Market report?

Ans: The Types covered in the Terbinafine (Lamisil) Market report are Oral, External Use

1 Terbinafine (Lamisil) Market Overview
1.1 Product Definition
1.2 Terbinafine (Lamisil) by Type
1.2.1 Global Terbinafine (Lamisil) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 External Use
1.3 Terbinafine (Lamisil) by Application
1.3.1 Global Terbinafine (Lamisil) Market Value by Application (2024 VS 2031)
1.3.2 Fungal Infection Of The Skin And Mucous Membrane
1.3.3 Onychomycosis
1.3.4 Bronchial Asthma
1.3.5 Gynecological Anti-Infection Preparation
1.3.6 Other
1.4 Global Terbinafine (Lamisil) Market Size Estimates and Forecasts
1.4.1 Global Terbinafine (Lamisil) Revenue 2020-2031
1.4.2 Global Terbinafine (Lamisil) Sales 2020-2031
1.4.3 Global Terbinafine (Lamisil) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Terbinafine (Lamisil) Market Competition by Manufacturers
2.1 Global Terbinafine (Lamisil) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Terbinafine (Lamisil) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Terbinafine (Lamisil) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Terbinafine (Lamisil), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Terbinafine (Lamisil), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Terbinafine (Lamisil), Product Type & Application
2.7 Global Key Manufacturers of Terbinafine (Lamisil), Date of Enter into This Industry
2.8 Global Terbinafine (Lamisil) Market Competitive Situation and Trends
2.8.1 Global Terbinafine (Lamisil) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Terbinafine (Lamisil) Players Market Share by Revenue
2.8.3 Global Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Terbinafine (Lamisil) Market Scenario by Region
3.1 Global Terbinafine (Lamisil) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Terbinafine (Lamisil) Sales by Region: 2020-2031
3.2.1 Global Terbinafine (Lamisil) Sales by Region: 2020-2025
3.2.2 Global Terbinafine (Lamisil) Sales by Region: 2026-2031
3.3 Global Terbinafine (Lamisil) Revenue by Region: 2020-2031
3.3.1 Global Terbinafine (Lamisil) Revenue by Region: 2020-2025
3.3.2 Global Terbinafine (Lamisil) Revenue by Region: 2026-2031
3.4 North America Terbinafine (Lamisil) Market Facts & Figures by Country
3.4.1 North America Terbinafine (Lamisil) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Terbinafine (Lamisil) Sales by Country (2020-2031)
3.4.3 North America Terbinafine (Lamisil) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Terbinafine (Lamisil) Market Facts & Figures by Country
3.5.1 Europe Terbinafine (Lamisil) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Terbinafine (Lamisil) Sales by Country (2020-2031)
3.5.3 Europe Terbinafine (Lamisil) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Terbinafine (Lamisil) Market Facts & Figures by Region
3.6.1 Asia Pacific Terbinafine (Lamisil) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Terbinafine (Lamisil) Sales by Region (2020-2031)
3.6.3 Asia Pacific Terbinafine (Lamisil) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Terbinafine (Lamisil) Market Facts & Figures by Country
3.7.1 Latin America Terbinafine (Lamisil) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Terbinafine (Lamisil) Sales by Country (2020-2031)
3.7.3 Latin America Terbinafine (Lamisil) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Terbinafine (Lamisil) Market Facts & Figures by Country
3.8.1 Middle East and Africa Terbinafine (Lamisil) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Terbinafine (Lamisil) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Terbinafine (Lamisil) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Terbinafine (Lamisil) Sales by Type (2020-2031)
4.1.1 Global Terbinafine (Lamisil) Sales by Type (2020-2025)
4.1.2 Global Terbinafine (Lamisil) Sales by Type (2026-2031)
4.1.3 Global Terbinafine (Lamisil) Sales Market Share by Type (2020-2031)
4.2 Global Terbinafine (Lamisil) Revenue by Type (2020-2031)
4.2.1 Global Terbinafine (Lamisil) Revenue by Type (2020-2025)
4.2.2 Global Terbinafine (Lamisil) Revenue by Type (2026-2031)
4.2.3 Global Terbinafine (Lamisil) Revenue Market Share by Type (2020-2031)
4.3 Global Terbinafine (Lamisil) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Terbinafine (Lamisil) Sales by Application (2020-2031)
5.1.1 Global Terbinafine (Lamisil) Sales by Application (2020-2025)
5.1.2 Global Terbinafine (Lamisil) Sales by Application (2026-2031)
5.1.3 Global Terbinafine (Lamisil) Sales Market Share by Application (2020-2031)
5.2 Global Terbinafine (Lamisil) Revenue by Application (2020-2031)
5.2.1 Global Terbinafine (Lamisil) Revenue by Application (2020-2025)
5.2.2 Global Terbinafine (Lamisil) Revenue by Application (2026-2031)
5.2.3 Global Terbinafine (Lamisil) Revenue Market Share by Application (2020-2031)
5.3 Global Terbinafine (Lamisil) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Perrigo
6.1.1 Perrigo Company Information
6.1.2 Perrigo Description and Business Overview
6.1.3 Perrigo Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Perrigo Terbinafine (Lamisil) Product Portfolio
6.1.5 Perrigo Recent Developments/Updates
6.2 Novartis Pharmaceuticals Corporation
6.2.1 Novartis Pharmaceuticals Corporation Company Information
6.2.2 Novartis Pharmaceuticals Corporation Description and Business Overview
6.2.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Portfolio
6.2.5 Novartis Pharmaceuticals Corporation Recent Developments/Updates
6.3 Gokul Pharma
6.3.1 Gokul Pharma Company Information
6.3.2 Gokul Pharma Description and Business Overview
6.3.3 Gokul Pharma Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gokul Pharma Terbinafine (Lamisil) Product Portfolio
6.3.5 Gokul Pharma Recent Developments/Updates
6.4 TEVA
6.4.1 TEVA Company Information
6.4.2 TEVA Description and Business Overview
6.4.3 TEVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 TEVA Terbinafine (Lamisil) Product Portfolio
6.4.5 TEVA Recent Developments/Updates
6.5 Mylan Pharmaceuticals
6.5.1 Mylan Pharmaceuticals Company Information
6.5.2 Mylan Pharmaceuticals Description and Business Overview
6.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Pharmaceuticals Terbinafine (Lamisil) Product Portfolio
6.5.5 Mylan Pharmaceuticals Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Terbinafine (Lamisil) Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Sivem Pharmaceuticals
6.7.1 Sivem Pharmaceuticals Company Information
6.7.2 Sivem Pharmaceuticals Description and Business Overview
6.7.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sivem Pharmaceuticals Terbinafine (Lamisil) Product Portfolio
6.7.5 Sivem Pharmaceuticals Recent Developments/Updates
6.8 Apotex Corporation
6.8.1 Apotex Corporation Company Information
6.8.2 Apotex Corporation Description and Business Overview
6.8.3 Apotex Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Apotex Corporation Terbinafine (Lamisil) Product Portfolio
6.8.5 Apotex Corporation Recent Developments/Updates
6.9 Auro Pharma Inc
6.9.1 Auro Pharma Inc Company Information
6.9.2 Auro Pharma Inc Description and Business Overview
6.9.3 Auro Pharma Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Auro Pharma Inc Terbinafine (Lamisil) Product Portfolio
6.9.5 Auro Pharma Inc Recent Developments/Updates
6.10 PLIVA
6.10.1 PLIVA Company Information
6.10.2 PLIVA Description and Business Overview
6.10.3 PLIVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 PLIVA Terbinafine (Lamisil) Product Portfolio
6.10.5 PLIVA Recent Developments/Updates
6.11 Jamp Pharma Corporation
6.11.1 Jamp Pharma Corporation Company Information
6.11.2 Jamp Pharma Corporation Description and Business Overview
6.11.3 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jamp Pharma Corporation Terbinafine (Lamisil) Product Portfolio
6.11.5 Jamp Pharma Corporation Recent Developments/Updates
6.12 Nu Pharm
6.12.1 Nu Pharm Company Information
6.12.2 Nu Pharm Description and Business Overview
6.12.3 Nu Pharm Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Nu Pharm Terbinafine (Lamisil) Product Portfolio
6.12.5 Nu Pharm Recent Developments/Updates
6.13 Codal Synto
6.13.1 Codal Synto Company Information
6.13.2 Codal Synto Description and Business Overview
6.13.3 Codal Synto Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Codal Synto Terbinafine (Lamisil) Product Portfolio
6.13.5 Codal Synto Recent Developments/Updates
6.14 Qd Pharmaceuticals
6.14.1 Qd Pharmaceuticals Company Information
6.14.2 Qd Pharmaceuticals Description and Business Overview
6.14.3 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Qd Pharmaceuticals Terbinafine (Lamisil) Product Portfolio
6.14.5 Qd Pharmaceuticals Recent Developments/Updates
6.15 Pharmel Inc
6.15.1 Pharmel Inc Company Information
6.15.2 Pharmel Inc Description and Business Overview
6.15.3 Pharmel Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Pharmel Inc Terbinafine (Lamisil) Product Portfolio
6.15.5 Pharmel Inc Recent Developments/Updates
6.16 Smaart Pharmaceutticals
6.16.1 Smaart Pharmaceutticals Company Information
6.16.2 Smaart Pharmaceutticals Description and Business Overview
6.16.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Smaart Pharmaceutticals Terbinafine (Lamisil) Product Portfolio
6.16.5 Smaart Pharmaceutticals Recent Developments/Updates
6.17 Qilu Pharmaceutical
6.17.1 Qilu Pharmaceutical Company Information
6.17.2 Qilu Pharmaceutical Description and Business Overview
6.17.3 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Qilu Pharmaceutical Terbinafine (Lamisil) Product Portfolio
6.17.5 Qilu Pharmaceutical Recent Developments/Updates
6.18 Qingdao Jinfeng Pharmaceutical
6.18.1 Qingdao Jinfeng Pharmaceutical Company Information
6.18.2 Qingdao Jinfeng Pharmaceutical Description and Business Overview
6.18.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Portfolio
6.18.5 Qingdao Jinfeng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Terbinafine (Lamisil) Industry Chain Analysis
7.2 Terbinafine (Lamisil) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Terbinafine (Lamisil) Production Mode & Process Analysis
7.4 Terbinafine (Lamisil) Sales and Marketing
7.4.1 Terbinafine (Lamisil) Sales Channels
7.4.2 Terbinafine (Lamisil) Distributors
7.5 Terbinafine (Lamisil) Customer Analysis
8 Terbinafine (Lamisil) Market Dynamics
8.1 Terbinafine (Lamisil) Industry Trends
8.2 Terbinafine (Lamisil) Market Drivers
8.3 Terbinafine (Lamisil) Market Challenges
8.4 Terbinafine (Lamisil) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Perrigo
Novartis Pharmaceuticals Corporation
Gokul Pharma
TEVA
Mylan Pharmaceuticals
Pfizer Inc
Sivem Pharmaceuticals
Apotex Corporation
Auro Pharma Inc
PLIVA
Jamp Pharma Corporation
Nu Pharm
Codal Synto
Qd Pharmaceuticals
Pharmel Inc
Smaart Pharmaceutticals
Qilu Pharmaceutical
Qingdao Jinfeng Pharmaceutical
List of Tables
 Table 1. Global Terbinafine (Lamisil) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Terbinafine (Lamisil) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Terbinafine (Lamisil) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Terbinafine (Lamisil) Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Terbinafine (Lamisil) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Terbinafine (Lamisil) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Terbinafine (Lamisil) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Terbinafine (Lamisil) Average Price (US$/G) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Terbinafine (Lamisil), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Terbinafine (Lamisil), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Terbinafine (Lamisil), Product Type & Application
 Table 12. Global Key Manufacturers of Terbinafine (Lamisil), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Terbinafine (Lamisil) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terbinafine (Lamisil) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Terbinafine (Lamisil) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Terbinafine (Lamisil) Sales by Region (2020-2025) & (KG)
 Table 18. Global Terbinafine (Lamisil) Sales Market Share by Region (2020-2025)
 Table 19. Global Terbinafine (Lamisil) Sales by Region (2026-2031) & (KG)
 Table 20. Global Terbinafine (Lamisil) Sales Market Share by Region (2026-2031)
 Table 21. Global Terbinafine (Lamisil) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Terbinafine (Lamisil) Revenue Market Share by Region (2020-2025)
 Table 23. Global Terbinafine (Lamisil) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Terbinafine (Lamisil) Revenue Market Share by Region (2026-2031)
 Table 25. North America Terbinafine (Lamisil) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Terbinafine (Lamisil) Sales by Country (2020-2025) & (KG)
 Table 27. North America Terbinafine (Lamisil) Sales by Country (2026-2031) & (KG)
 Table 28. North America Terbinafine (Lamisil) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Terbinafine (Lamisil) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Terbinafine (Lamisil) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Terbinafine (Lamisil) Sales by Country (2020-2025) & (KG)
 Table 32. Europe Terbinafine (Lamisil) Sales by Country (2026-2031) & (KG)
 Table 33. Europe Terbinafine (Lamisil) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Terbinafine (Lamisil) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Terbinafine (Lamisil) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Terbinafine (Lamisil) Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Terbinafine (Lamisil) Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Terbinafine (Lamisil) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Terbinafine (Lamisil) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Terbinafine (Lamisil) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Terbinafine (Lamisil) Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Terbinafine (Lamisil) Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Terbinafine (Lamisil) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Terbinafine (Lamisil) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Terbinafine (Lamisil) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Terbinafine (Lamisil) Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Terbinafine (Lamisil) Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Terbinafine (Lamisil) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Terbinafine (Lamisil) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Terbinafine (Lamisil) Sales (KG) by Type (2020-2025)
 Table 51. Global Terbinafine (Lamisil) Sales (KG) by Type (2026-2031)
 Table 52. Global Terbinafine (Lamisil) Sales Market Share by Type (2020-2025)
 Table 53. Global Terbinafine (Lamisil) Sales Market Share by Type (2026-2031)
 Table 54. Global Terbinafine (Lamisil) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Terbinafine (Lamisil) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Terbinafine (Lamisil) Revenue Market Share by Type (2020-2025)
 Table 57. Global Terbinafine (Lamisil) Revenue Market Share by Type (2026-2031)
 Table 58. Global Terbinafine (Lamisil) Price (US$/G) by Type (2020-2025)
 Table 59. Global Terbinafine (Lamisil) Price (US$/G) by Type (2026-2031)
 Table 60. Global Terbinafine (Lamisil) Sales (KG) by Application (2020-2025)
 Table 61. Global Terbinafine (Lamisil) Sales (KG) by Application (2026-2031)
 Table 62. Global Terbinafine (Lamisil) Sales Market Share by Application (2020-2025)
 Table 63. Global Terbinafine (Lamisil) Sales Market Share by Application (2026-2031)
 Table 64. Global Terbinafine (Lamisil) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Terbinafine (Lamisil) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Terbinafine (Lamisil) Revenue Market Share by Application (2020-2025)
 Table 67. Global Terbinafine (Lamisil) Revenue Market Share by Application (2026-2031)
 Table 68. Global Terbinafine (Lamisil) Price (US$/G) by Application (2020-2025)
 Table 69. Global Terbinafine (Lamisil) Price (US$/G) by Application (2026-2031)
 Table 70. Perrigo Company Information
 Table 71. Perrigo Description and Business Overview
 Table 72. Perrigo Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 73. Perrigo Terbinafine (Lamisil) Product
 Table 74. Perrigo Recent Developments/Updates
 Table 75. Novartis Pharmaceuticals Corporation Company Information
 Table 76. Novartis Pharmaceuticals Corporation Description and Business Overview
 Table 77. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 78. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product
 Table 79. Novartis Pharmaceuticals Corporation Recent Developments/Updates
 Table 80. Gokul Pharma Company Information
 Table 81. Gokul Pharma Description and Business Overview
 Table 82. Gokul Pharma Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 83. Gokul Pharma Terbinafine (Lamisil) Product
 Table 84. Gokul Pharma Recent Developments/Updates
 Table 85. TEVA Company Information
 Table 86. TEVA Description and Business Overview
 Table 87. TEVA Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 88. TEVA Terbinafine (Lamisil) Product
 Table 89. TEVA Recent Developments/Updates
 Table 90. Mylan Pharmaceuticals Company Information
 Table 91. Mylan Pharmaceuticals Description and Business Overview
 Table 92. Mylan Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 93. Mylan Pharmaceuticals Terbinafine (Lamisil) Product
 Table 94. Mylan Pharmaceuticals Recent Developments/Updates
 Table 95. Pfizer Company Information
 Table 96. Pfizer Description and Business Overview
 Table 97. Pfizer Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 98. Pfizer Terbinafine (Lamisil) Product
 Table 99. Pfizer Recent Developments/Updates
 Table 100. Sivem Pharmaceuticals Company Information
 Table 101. Sivem Pharmaceuticals Description and Business Overview
 Table 102. Sivem Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 103. Sivem Pharmaceuticals Terbinafine (Lamisil) Product
 Table 104. Sivem Pharmaceuticals Recent Developments/Updates
 Table 105. Apotex Corporation Company Information
 Table 106. Apotex Corporation Description and Business Overview
 Table 107. Apotex Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 108. Apotex Corporation Terbinafine (Lamisil) Product
 Table 109. Apotex Corporation Recent Developments/Updates
 Table 110. Auro Pharma Inc Company Information
 Table 111. Auro Pharma Inc Description and Business Overview
 Table 112. Auro Pharma Inc Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 113. Auro Pharma Inc Terbinafine (Lamisil) Product
 Table 114. Auro Pharma Inc Recent Developments/Updates
 Table 115. PLIVA Company Information
 Table 116. PLIVA Description and Business Overview
 Table 117. PLIVA Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 118. PLIVA Terbinafine (Lamisil) Product
 Table 119. PLIVA Recent Developments/Updates
 Table 120. Jamp Pharma Corporation Company Information
 Table 121. Jamp Pharma Corporation Description and Business Overview
 Table 122. Jamp Pharma Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 123. Jamp Pharma Corporation Terbinafine (Lamisil) Product
 Table 124. Jamp Pharma Corporation Recent Developments/Updates
 Table 125. Nu Pharm Company Information
 Table 126. Nu Pharm Description and Business Overview
 Table 127. Nu Pharm Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 128. Nu Pharm Terbinafine (Lamisil) Product
 Table 129. Nu Pharm Recent Developments/Updates
 Table 130. Codal Synto Company Information
 Table 131. Codal Synto Description and Business Overview
 Table 132. Codal Synto Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 133. Codal Synto Terbinafine (Lamisil) Product
 Table 134. Codal Synto Recent Developments/Updates
 Table 135. Qd Pharmaceuticals Company Information
 Table 136. Qd Pharmaceuticals Description and Business Overview
 Table 137. Qd Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 138. Qd Pharmaceuticals Terbinafine (Lamisil) Product
 Table 139. Qd Pharmaceuticals Recent Developments/Updates
 Table 140. Pharmel Inc Company Information
 Table 141. Pharmel Inc Description and Business Overview
 Table 142. Pharmel Inc Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 143. Pharmel Inc Terbinafine (Lamisil) Product
 Table 144. Pharmel Inc Recent Developments/Updates
 Table 145. Smaart Pharmaceutticals Company Information
 Table 146. Smaart Pharmaceutticals Description and Business Overview
 Table 147. Smaart Pharmaceutticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 148. Smaart Pharmaceutticals Terbinafine (Lamisil) Product
 Table 149. Smaart Pharmaceutticals Recent Developments/Updates
 Table 150. Qilu Pharmaceutical Company Information
 Table 151. Qilu Pharmaceutical Description and Business Overview
 Table 152. Qilu Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 153. Qilu Pharmaceutical Terbinafine (Lamisil) Product
 Table 154. Qilu Pharmaceutical Recent Developments/Updates
 Table 155. Qingdao Jinfeng Pharmaceutical Company Information
 Table 156. Qingdao Jinfeng Pharmaceutical Description and Business Overview
 Table 157. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 158. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product
 Table 159. Qingdao Jinfeng Pharmaceutical Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Terbinafine (Lamisil) Distributors List
 Table 163. Terbinafine (Lamisil) Customers List
 Table 164. Terbinafine (Lamisil) Market Trends
 Table 165. Terbinafine (Lamisil) Market Drivers
 Table 166. Terbinafine (Lamisil) Market Challenges
 Table 167. Terbinafine (Lamisil) Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Terbinafine (Lamisil)
 Figure 2. Global Terbinafine (Lamisil) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Terbinafine (Lamisil) Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. External Use Product Picture
 Figure 6. Global Terbinafine (Lamisil) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Terbinafine (Lamisil) Market Share by Application: 2024 & 2031
 Figure 8. Fungal Infection Of The Skin And Mucous Membrane
 Figure 9. Onychomycosis
 Figure 10. Bronchial Asthma
 Figure 11. Gynecological Anti-Infection Preparation
 Figure 12. Other
 Figure 13. Global Terbinafine (Lamisil) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Terbinafine (Lamisil) Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Terbinafine (Lamisil) Sales (2020-2031) & (KG)
 Figure 16. Global Terbinafine (Lamisil) Average Price (US$/G) & (2020-2031)
 Figure 17. Terbinafine (Lamisil) Report Years Considered
 Figure 18. Terbinafine (Lamisil) Sales Share by Manufacturers in 2024
 Figure 19. Global Terbinafine (Lamisil) Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Terbinafine (Lamisil) Players: Market Share by Revenue in Terbinafine (Lamisil) in 2024
 Figure 21. Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Terbinafine (Lamisil) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Terbinafine (Lamisil) Sales Market Share by Country (2020-2031)
 Figure 24. North America Terbinafine (Lamisil) Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Terbinafine (Lamisil) Sales Market Share by Country (2020-2031)
 Figure 28. Europe Terbinafine (Lamisil) Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Terbinafine (Lamisil) Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Terbinafine (Lamisil) Revenue Market Share by Region (2020-2031)
 Figure 36. China Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Terbinafine (Lamisil) Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Terbinafine (Lamisil) Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Terbinafine (Lamisil) Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Terbinafine (Lamisil) Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Terbinafine (Lamisil) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Terbinafine (Lamisil) by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Terbinafine (Lamisil) by Type (2020-2031)
 Figure 58. Global Terbinafine (Lamisil) Price (US$/G) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Terbinafine (Lamisil) by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Terbinafine (Lamisil) by Application (2020-2031)
 Figure 61. Global Terbinafine (Lamisil) Price (US$/G) by Application (2020-2031)
 Figure 62. Terbinafine (Lamisil) Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Terbinafine Hydrochloride Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Terbinafine Hydrochloride Cream Market Research Report 2024
Global Naftifine Hydrochloride Ointment Market Insights Forecast to 2030
Global Antifungal and Ringworm Treatment Drugs Market Research Report 2025
Global Terbinafine Hydrochloride Market Research Report 2024
Global Oral Terazosin Hydrochloride Market Research Report 2024
Global Terbinafine Hydrochloride API Market Research Report 2024
Global Prenylamine Lactic Acid Tabelts Market Research Report 2024
Global Bisdisulizole Disodium Market Research Report 2024
Global Amorofen Hydrochloride Liniment Market Research Report 2024
Global Synthetic Betulinic Acid Market Research Report 2025
Global Imidazolidinyl Urea Market Research Report 2024
Global Secoisolariciresinol Market Research Report 2024
Global N Allylamine Market Research Report 2024
Global Racemic Anisodamine Hydrochloride Injection Market Research Report 2025
Global N N Ethylenebis Stearamide Market Research Report 2024
Global Moclobemide Tablet Market Research Report 2025
Global Terbinafine Hydrochloride Spray Market Research Report 2024
Global Teriflunomide Market Research Report 2024
Global Selegiline Hydrochloride Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions